• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human ADP-ribosylation factor-like protein 11 (ARL11)

ACP13251

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13251 Target NameARL11
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range2-196Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ969Q4
Background Information
  • Uniprot Id

    Q969Q4

  • Target Species

    Human

  • Target Name

    ARL11

  • Target Full Name

    ADP-ribosylation factor-like protein 11

  • Target Function

    May play a role in apoptosis. May act as a tumor suppressor.

  • Target Involvement

    Leukemia, chronic lymphocytic (CLL)

  • Target Protein Families

    Small GTPase superfamily, Arf family

  • Target Tissue Specificity

    Expressed in lung and leukocytes.

  • Target Synonyms

    ADP ribosylation factor like 11; ADP ribosylation factor like protein 11; ADP ribosylation factor like tumor suppressor protein 1; ADP-ribosylation factor-like protein 11; ADP-ribosylation factor-like tumor suppressor protein 1; ARL11; ARL11_HUMAN; ARLTS1

  • Target Background

    This gene encodes a tumor suppressor related to the ADP-ribosylation factor (ARF) family of proteins. The encoded protein may play a role in apoptosis in a caspase-dependent manner. Polymorphisms in this gene have been associated with some familial cancers.

Inquire Recombinant Human ADP-ribosylation factor-like protein 11 (ARL11) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification